News

Careful Use of Gout Drugs Can End Acute Attacks


 

General internists often continue to treat gout the way they were taught to as medical students, and the result of that approach has been that patients continue to have gout attacks and joint damage. Physicians can do much better than that by using available medications to lower the patient’s serum urate level below 6 mg/dL, according to Dr. Brian Mandell, Professor and Chairman of Medicine at the Cleveland Clinic. This interview was conducted at the 5th Annual Perspectives in Rheumatic Diseases Seminar.

Recommended Reading

Gout by the Numbers
MDedge Rheumatology
Gout Prevalence on the Upswing, MDs on the Downswing
MDedge Rheumatology
To Reverse Metabolic Syndrome, Take Gout by the Horns
MDedge Rheumatology
Novel Gout Treatment Boosts Response in Allopurinol Nonresponders
MDedge Rheumatology
Obesity Epidemic Is Skewing Face of Gout
MDedge Rheumatology
Physicians Often Missing Boat on Gout Therapy
MDedge Rheumatology
Colchicine Halved MI Risk in Gout
MDedge Rheumatology
Gout Prevalence Has Spiked
MDedge Rheumatology
Biologic Gout Drug Fails the FDA Panel Sniff Test
MDedge Rheumatology
New Gout Guidelines Inspired by Recent Data
MDedge Rheumatology